Tag
Anti-infectives
2 articles
Gujarat Themis Biosyn Acquires Sanofi TB Portfolio
Gujarat Themis Biosyn announces €158M acquisition of Sanofi's global anti-TB and anti-infective product portfolio.
The asset-light acquisition includes 13 products across 55+ countries with €62M FY202
Gujarat Themis Acquires Sanofi Anti-TB Portfolio for €158M
Gujarat Themis Biosyn signs agreement to acquire Sanofi's global anti-TB and anti-infective portfolio of 13 brands across 55+ countries.
The €158 million cash transaction includes marketing authorizat